PENTHROX™ in the Canadian Emergency Department (ED)
Status:
Completed
Trial end date:
2020-09-08
Target enrollment:
Participant gender:
Summary
This Canadian, multi-centre, prospective, real world study is designed to evaluate the
effectiveness of low dose methoxyflurane (MEOF) (PENTHROX™) for the treatment of moderate to
severe pain associated with trauma in the Canadian ED.